ArticleExperimental and therapeutic medicine2012

Construction of PR39 recombinant AAV under control of the HRE promoter and the effect of recombinant AAV on gene therapy of ischemic heart disease.

Lijun Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.